Patents by Inventor Naomi Hashimura

Naomi Hashimura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Rheumatoid arthritis-preventive agent for oral intake
    Patent number: 8367614
    Abstract: There is provided a rheumatoid arthritis inhibitor for oral intake that has an inhibitory effect on rheumatoid arthritis and is excellent in safety. The rheumatoid arthritis inhibitor for oral intake of the present invention contains, as an active component, a casein hydrolysate containing free amino acids and peptides obtained by hydrolyzing animal milk casein to have an average chain length of not longer than 2.1 in terms of the number of amino acid residues, or a mixture of free amino acids and peptides contained in the hydrolysate.
    Type: Grant
    Filed: June 15, 2011
    Date of Patent: February 5, 2013
    Assignee: Calpis Co., Ltd
    Inventors: Michio Hatori, Kohji Ohki, Naomi Hashimura, Tatsuhiko Hirota, Kazuhito Ohsawa
  • RHEUMATOID ARTHRITIS-PREVENTIVE AGENT FOR ORAL INTAKE
    Publication number: 20110251129
    Abstract: There is provided a rheumatoid arthritis inhibitor for oral intake that has an inhibitory effect on rheumatoid arthritis and is excellent in safety. The rheumatoid arthritis inhibitor for oral intake of the present invention contains, as an active component, a casein hydrolysate containing free amino acids and peptides obtained by hydrolyzing animal milk casein to have an average chain length of not longer than 2.1 in terms of the number of amino acid residues, or a mixture of free amino acids and peptides contained in the hydrolysate.
    Type: Application
    Filed: June 15, 2011
    Publication date: October 13, 2011
    Applicant: CALPIS CO., LTD.
    Inventors: Michio HATORI, Kohji OHKI, Naomi HASHIMURA, Tatsuhiko HIROTA, Kazuhito OHSAWA
  • RHEUMATOID ARTHRITIS-PREVENTIVE AGENT FOR ORAL INTAKE
    Publication number: 20100167979
    Abstract: There is provided a rheumatoid arthritis inhibitor for oral intake that has an inhibitory effect on rheumatoid arthritis and is excellent in safety. The rheumatoid arthritis inhibitor for oral intake of the present invention contains, as an active component, a casein hydrolysate containing free amino acids and peptides obtained by hydrolyzing animal milk casein to have an average chain length of not longer than 2.1 in terms of the number of amino acid residues, or a mixture of free amino acids and peptides contained in the hydrolysate.
    Type: Application
    Filed: February 9, 2007
    Publication date: July 1, 2010
    Applicant: CALPIS CO. LTD
    Inventors: Michio Hatori, Kohji Ohki, Naomi Hashimura, Tatsuhiko Hirota, Kazuhito Ohsawa